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Use of Colorimetric Culture Methods for Detection of Mycobacterium
tuberculosis Complex Isolates from Sputum Samples in Resource-
Limited Settings
Yap Boum II,a,d Patrick Orikiriza,a Gabriel Rojas-Ponce,a,c Margarita Riera-Montes,a Daniel Atwine,a Margaret Nansumba,a Joel Bazira,d
Eleanor Tuyakira,a,d Pierre De Beaudrap,a,e Maryline Bonnet,b Anne-Laure Pageb
Epicentre Mbarara, Mbarara, Ugandaa; Epicentre, Paris, Franceb; Mbeya Medical Research Program, Mbeya, Tanzaniac; Mbarara University of Science and Technology,
Mbarara, Ugandad; UMI 233, Institut de Recherche pour le Développement, Université de Montpellier I, Montpellier, Francee
Despite recent advances, tuberculosis (TB) diagnosis remains imperfect in resource-limited settings due to its complexity and
costs, poor sensitivity of available tests, or long times to reporting. We present a report on the use of colorimetric methods,
based on the detection of mycobacterial growth using colorimetric indicators, for the detection ofMycobacterium tuberculosis in
sputum specimens. We evaluated the nitrate reductase assay (NRA), a modified NRA using para-nitrobenzoic acid (PNB)
(NRAp), and the resazurin tube assay using PNB (RETAp) to differentiate tuberculous and nontuberculous mycobacteria. The
performances were assessed at days 18 and 28 using mycobacterium growth indicator tube (MGIT) and Löwenstein-Jensen (LJ)
medium culture methods as the reference standards. We enrolled 690 adults with suspected pulmonary tuberculosis from a re-
gional referral hospital in Uganda betweenMarch 2010 and June 2011. At day 18, the sensitivities and specificities were 84.6%
and 90.0% for the NRA, 84.1% and 92.6% for the NRAp, and 71.2% and 99.3% for the RETAp, respectively. At day 28, the sensi-
tivity of the RETAp increased to 82.6%. Among smear-negative patients with suspected TB, sensitivities at day 28 were 64.7% for
the NRA, 61.3% for the NRAp, and 50% for the RETAp. Contamination rates were found to be 5.4% for the NRA and 6.7% for
the RETAp, compared with 22.1% for LJ medium culture and 20.4% for MGIT culture. The median times to positivity were 10, 7,
and 25 days for colorimetric methods, MGIT culture, and LJ medium culture,respectively. Whereas the low specificity of the
NRA/NRAp precludes it from being used for TB diagnosis, the RETApmight provide an alternative to LJ medium culture to de-
crease the time to culture results in resource-poor settings.
Tuberculosis (TB) presents a large burden in developing coun-tries, where its diagnosis relies mainly on smear microscopy
(1). Although it is simple, fast, and inexpensive, microscopy has
low and variable sensitivity (20 to 60%) (2), especially among
patients coinfected with HIV (3).Culture is the reference standard
but is not readily available in these countries. In addition, growth
in the solid culture medium (Löwenstein-Jensen [LJ] medium) is
too slow (3 to 8 weeks) to have an impact on patient management.
Liquid culture in a mycobacterium growth indicator tube
(MGIT) is more rapid (10 days) and sensitive than culture in LJ
medium but is costly and is more susceptible to contamination
(4). Molecular approaches such as the Xpert MTB/RIF assay (5)
reduce the time to detection (5, 6) and have been endorsed by the
WHO (7, 8). Although they are sensitive, rapid, and relatively easy
to use, these tests are costly and cannot completely replace culture,
since they do not allow for the full range of drug sensitivity testing
and Mycobacterium tuberculosis strain isolation (5, 9, 10).
Noncommercial alternative culture methods have been devel-
oped to reduce assay times and costs. Thin-layer agar (TLA) cul-
ture and microscopic observation drug susceptibility (MODS) as-
says (9, 10) have shown good sensitivity and specificity, compared
with culture in LJ medium, and decreased time to detection (11.5
and 7 days, respectively). Both methods, however, require specific
equipment in addition to the regular TB culture infrastructure,
i.e., an inverted microscope for MODS assays and a CO2 incubator
for TLA culture (9, 10). In addition, they require well-trained and
experienced personnel for accurate reading.
Colorimetric methods currently are used for rapid identifica-
tion and drug sensitivity testing of M. tuberculosis (11–15). These
methods rely on the detection of live bacteria through enzymatic
activity. Results are obtained by direct interpretation of the me-
dium color and testing can be performed with minimal TB culture
infrastructure, at relatively low cost (16).
The resazurin microtiter assay (REMA) relies on the ability of
live bacteria to reduce the oxidation-reduction indicator resazurin
in liquid medium (12, 17, 18). The nitrate reductase assay (NRA)
is based on the ability of M. tuberculosis to reduce nitrate in solid
medium (16). Drug sensitivity results can be obtained with the
two methods in 7 days from isolates and in 14 days from sputum
samples, with excellent sensitivity and specificity in comparison
with the proportion method using LJ medium (15, 19, 20). REMA
and NRA are endorsed by the WHO for rapid drug sensitivity
testing from primary cultures for colorimetric redox indicator
methods and from smear-positive sputum or primary cultures for
NRA (8, 21). None of these methods has been evaluated for pri-
mary detection of M. tuberculosis in sputum specimens from pa-
tients with suspected TB.
In this study, we hypothesized that these methods might be
applied for primary M. tuberculosis detection in sputum samples
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from patients with suspected pulmonary TB. For differentiation
between M. tuberculosis and nontuberculous mycobacteria
(NTM), we modified the resazurin tube assay (RETA) method
with the addition of an identification step using a tube containing
para-nitrobenzoic acid (PNB), which inhibits the growth of M.
tuberculosis but not NTM (i.e., RETA with PNB [RETAp]). Since
nitrate reduction is one of the biochemical tests used for the dif-
ferentiation of M. tuberculosis and NTM, we evaluated the NRA
method both with (NRAp) and without (NRA) the identification
step using PNB.
The objective of this study was to evaluate the performance and
feasibility of RETAp, NRA, and NRAp for the detection of M.
tuberculosis complex (MTBC) from sputum in a setting with high
prevalence rates of TB and HIV. We aimed to determine the per-
formance of colorimetric assays in comparison with LJ medium
culture and manual MGIT culture for all, HIV-positive, and
smear-negative patients with suspected pulmonary TB.
MATERIALS AND METHODS
Participants. We enrolled participants from the outpatient depart-
ment and immune suppression syndrome (HIV) clinic at the Mbarara
Regional Referral Hospital in southwestern Uganda from March 2010
through June 2011. Patients were eligible if they reported a cough for more
than 2 weeks, were at least 15 years of age, and signed an informed-consent
form. We excluded patients with grossly bloody sputum or clear saliva,
those who could not produce at least 1 ml of sputum, and those who had
received anti-TB treatment for at least 1 week in the month before enroll-
ment.
The sample size of 690 patients was estimated based on the following
hypotheses. We needed 96 culture-positive samples to estimate an ex-
pected sensitivity of 90% with a precision of 6%. With an expected pro-
portion of 20% culture-positive pulmonary TB cases, we needed to enroll
480 patients. The sample size was increased to 690 to stratify the analysis
for smear-negative patients with suspected TB, who represented 80% of
the overall number of patients with suspected TB, and to take into account
a potential dropout rate of 15% (22). The study protocol was approved by
the Mbarara University Faculty of Medicine Research and Ethics Com-
mittee and Institutional Ethics Committee, the Uganda National Council
for Science and Technology, and the Comité de Protection des Personnes,
Ile de France XI, Saint-Germain en Laye, France.
Clinical assessment, chest radiography, and HIV testing. All study
participants underwent a physical assessment performed by a clinical of-
ficer and an anteroposterior chest X-ray. The study clinician recorded
chest radiographic findings according to a predetermined pictorial tick-
sheet, with final classification of the X-ray as “normal,” “abnormal, pos-
sible TB,” or “highly suggestive of TB.” Quality assurance consisted of
paired interpretation of 10% of the X-rays by the hospital radiologist. HIV
testing was performed for all patients who agreed, after they received
pretest counseling and signed a separate informed-consent form. HIV
testing was performed according to the national algorithm using Deter-
mine HIV-1/2/O (Abbott Laboratories, Abbott Park, IL) and HIV 1/2
Stat-Pak Ultra Fast (Chembio Diagnostic Systems, Medford, NY) tests,
with the Uni-Gold recombinant HIV-1/2 (Trinity Biotech, Bray, Ireland)
test for discordant results between the first two tests.
Tuberculosis laboratory procedures. (i) Microscopy and reference
culture methods. We collected sputum samples on the spot and the next
morning. We used the light-emitting diode-auramine fluorescence tech-
nique for direct microscopy on each specimen (22–25) and reported the
results according to the WHO grading scale (19). The reference standard
and colorimetric methods were performed with the best-quality specimen
according to the laboratory technician’s assessment. The specimen was
then decontaminated using theN-acetyl-L-cysteine (0.5%)-NaOH (1.5%)
method (26).
For the reference culture methods, we inoculated 100l of decontam-
inated sputum into two homemade LJ medium tubes and 500l into one
manual-testing MGIT (Becton, Dickinson, Franklin Lakes, NJ). We re-
ported a negative culture result after 56 days of incubation. Liquefied or
discolored LJ medium indicated contamination. Contamination from
growth in an MGIT was ruled out using Ziehl-Neelsen (ZN) microscopy
and culture on blood agar. For all positive LJ medium and MGIT cultures,
we differentiated between M. tuberculosis and NTM using the SD TB Ag
MPT64 Rapid system (SD Bioline, Kyongi-do, South Korea), following
the manufacturer’s instructions. The GenoType Mycobacterium CM/AS
identification kit (Hain Lifescience, Nehren, Germany) was used for iden-
tification of NTM.
(ii) Colorimetric methods. For the RETAp, we inoculated 100 l of
decontaminated sample into each of four 1.5-ml microtubes containing
500l of supplemented liquid medium (Middlebrook 7H9 medium sup-
plemented with oleic acid, albumin, dextrose, and catalase, with 0.5%
glycerol, 0.01% Casitone, and polymixin B-amphotericin B-nalidixic ac-
id-trimethoprim-azlocillin [PANTA]) (17) and one microtube contain-
ing 500 l of the same medium with PNB (500 g/ml). After incubating
the sample for 10 days at 37°C, we added 75 l of resazurin solution
(0.01%; Sigma-Aldrich, St. Louis, MO) to the first microtube and incu-
bated the mixture overnight at 37°C. If a color change from blue (oxidized
state) to pink (reduced state) occurred, indicating growth of the bacteria,
then we inoculated one drop of the mixture on blood agar and we used
one drop for ZN smear microscopy. If there was growth on blood agar and
no acid-fast bacilli (AFB) were seen, then we reported the tube as contam-
inated. We considered the result to be indeterminate if there was no
growth on blood agar and no AFB were seen or there was growth on blood
agar and AFB were seen. All positive cultures (AFB with negative blood
agar results) were identified asM. tuberculosis or NTM by treating the tube
containing PNB with resazurin. A color change in the tube containing
PNB was considered indicative of NTM, while no color change in the tube
was considered indicative of M. tuberculosis. If there was no color change
in the first tube at day 10, then the other tubes were tested on days 14, 18,
and 28, using the same procedure. If there was no color change in the final
tube (day 18 or day 28), then the sample was considered negative. If the
final tube was contaminated, then the sample was considered to be con-
taminated.
For the NRA, we inoculated 200 l of decontaminated sample into
four tubes of LJ medium containing a final concentration of 1 g/liter of
potassium nitrate (Sigma-Aldrich, St. Louis, MO) and one tube of LJ
medium containing the same concentration of potassium nitrate with
PNB (500 g/ml). After incubating the samples for 10 days at 37°C, we
added 500 l of fresh reagent mixture (1 part 50% concentrated hydro-
chloric acid, 2 parts 0.2% sulfanilamide, and 2 parts 0.1% N-[1-naph-
thyl]ethylenediamine dihydrochloride) to the first tube. If the color of the
reagent mixture changed to purple immediately after the addition of the
reagent to this tube, we considered the result to be positive. For NRA
interpretation, a positive result was considered positive for M. tuberculo-
sis. For the NRAp, the NRA PNB tube was treated similarly; the test was
considered positive for MTBC if there was no color change and positive
for NTM if there was a color change. Culture results were interpreted in
isolation from all other clinical and laboratory results.
(iii) Quality control and quality assessment. We randomly selected
10% of all sputum smear slides and all slides with positive or scanty results
that were read in duplicate for internal quality control. Discrepancies were
resolved by the TB laboratory supervisor. Our laboratory participates in a
proficiency scheme with the National Health Laboratory Services in South
Africa for external quality control of TB cultures and smear microscopy.
Statistical analysis. Data were double-entered using Voozanoo soft-
ware (EpiConcept, Paris, France). Statistical analysis was performed using
Stata SE v.11 software (StataCorp, College Station, TX).
We considered a sample positive by the standard method if MTBC was
isolated from either LJ medium or an MGIT. We considered a sample
negative if both results were negative or if one culture was negative and the
other was contaminated. For each colorimetric assay, performance was
Boum et al.
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calculated by estimating the sensitivity, specificity, positive and negative
predictive values, and positive and negative likelihood ratios, with their
95% confidence intervals (CIs). Contaminated and positive culture re-
sults for NTM with either the reference standard or the tested culture
methods were excluded from the analysis of performance. The perfor-
mances of the NRA and RETAp were estimated separately after 18 and 28
days of incubation. Analysis was performed for all smear-negative and
HIV-infected patients with suspected pulmonary TB. In a secondary anal-
ysis, we compared the M. tuberculosis recovery rates between the RETAp
and LJ medium culture among MGIT-positive cases by using a McNemar
test. We described the median times (with interquartile ranges [IQRs]) to
culture positivity for the different culture methods.
For the feasibility assessment, laboratory technicians were asked, after
the conclusion of the study, to complete an ease-of-use questionnaire on
preparation of the culture media, processing of the specimens, and read-
ing of the results. We calculated the costs of reagents and materials for the
different methods.
RESULTS
Participants. We screened 1,071 patients with suspected TB and
included 671 patients (62.7%) in the final analysis (Fig. 1). Partic-
ipant characteristics are presented in Table 1. Of these 671 pa-
tients, 590 patients (87.9%) provided two specimens. The speci-
men selected for the study was the early-morning specimen for
529 subjects (78.8%). The macroscopic appearance was purulent-
mucopurulent for 212 samples (31.6%), mucoid for 446 (66.5%),
blood-stained for 2 (0.3%), salivary for 2 (0.3%), and unknown
for 9 (1.3%). We detected 108 patients (16.1%) with positive
smear results among the 671 patients included in the analysis.
Reference culture results. Of the 671 patients included in the
analysis, LJ medium culture results were M. tuberculosis positive
for 107 (16.0%), NTM positive for 4 (0.06%), negative for 416
(62.0%), and contaminated for 148 (22.1%). MGIT results were
M. tuberculosis positive for 142 patients (21.2%), NTM positive
for 8 (1.2%), negative for 392 (58.4%), and contaminated for 137
(20.4%). When MGIT and LJ methods were combined, 46 (6.9%)
and 8 (1.2%) patients had final contaminated culture and NTM
results, respectively. After the exclusion of contaminated and
NTM results, the reference standard results were positive for 148
patients (23.7%). The proportions of MTBC culture-positive re-
sults with the reference method were 6.2% (35/563 patients)
among smear-negative patients and 21.8% (73/335 patients)
among HIV-infected patients.
Colorimetric assay results. The results of the NRA, NRAp,
and RETAp after 18 days of incubation, cross-tabulated with the
reference culture results, are shown in Table 2. At day 28, in com-
parison with day 18, an additional 19 MTBC cases were identified
by the RETAp, for an incremental yield of 18.1% (19/105 pa-
tients), and 13 by the NRA or NRAp, for incremental yields of
8.7% (13/149 patients) for the NRA and 7.5% (13/174 patients)
for the NRAp (Table 3). Accordingly, the sensitivities of the three
methods increased between day 18 and day 28, while the specific-
ities decreased slightly (Tables 4 and 5). Sensitivities were lower
among smear-negative and HIV-infected patients than among all
patients with suspected TB (Tables 4 and 5).
There were 53 false-positive results with the NRA methods,
Patients screened
n=1071
381 Not Recruited
unable to produce sputum  (n =170)
refuse to consent ( n=71)
patient too weak (  n=65)
bloody stained sputum ( n=33)
patient has no time ( n=33)
cough less than 2 weeks ( n =1)
patient on treatment for more than 1 month
Others (n=7)
(n =1)
Recruited in the Study
n=690
NRA 
n=671 
RETAp
n=671
Exclusions 
Contaminated NRAn=45
Contaminated GSn=46
NTM GS n=8
GS 
 Positive
n=115 
GS
Negative 
n =45
GS
Positive 
n =21
GS
Negative
n=399
GS
Positive
n=99
GS
Negative
n=3
GS
Positive
n=40
GS
Negative
n=450
Positive 
n =160
Negative
n =420
Positive
n =102
Negative
n=490
Revised exclusions
Cough less than 2 weeks ( n=2)
Sputum amount less than 1mL  (n=17)
Included in the analysis
n =671
Exclusions
Contaminated  RETAp    n     =36
Contaminated GS n=46
NTM GS n=8
NRAp
n=671
Exclusions
Contaminated NRAp   n  =45
Contaminated GSn=46
NTM GS n=8
GS
 Positive
n=111
GS
Negative
n=32
GS
Positive
n=21
GS 
Negative
n=399 
Positive
n=143
Negative 
n=420
FIG 1 Recruitment of patients and culture results. GS, gold standard method.
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among which the NRAp classified 13 cases as NTM. Among the 40
cases classified as MTBC by the NRAp, chest radiographic results
were classified as possible or highly suggestive of TB in 45.5%
(15/33 cases); 73.0% of patients (27/37 patients) were HIV posi-
tive, and one was smear positive (2.5%). Results of both reference
culture methods were negative for 19 of the false-positive NRAp
specimens (47.5%), while one result was negative and the other
contaminated for the remaining 21 specimens (52.5%). Of the 142
specimens that were positive by MGIT culture, 101 (71%) were
positive by LJ medium culture and 111 (78%) by the RETAp at day
28 (P  0.099); however, there were 20 (14%) contaminated re-
sults for LJ medium culture, compared with 0 (0%) for the
RETAp.
Time topositivity.The median times to positivity were 10 days
(IQR, 10 to 14 days) for the NRA, 10 days (IQR, 10 to 14 days) for
the NRAp, and 10 days (IQR, 10 to 18 days) for the RETAp. In
comparison, the median times to positivity were 7 days (IQR, 4 to
11 days) for MGIT culture and 25 days (IQR, 21 to 35 days) for LJ
medium culture. The NRA/NRAp detected 93.1% of positive cul-
ture specimens and the RETAp detected 84.8% by day 18 of incu-
bation (Fig. 2).
Feasibility and cost. Each medium was prepared locally, was
stored at room temperature, and cost less than $1 for the RETAp
or NRA. The analysis of one sample cost $0.5 and $10 for LJ me-
dium culture and MGIT culture, respectively. Laboratory techni-
cians reported high acceptability and feasibility for the colorimet-
ric assays.
DISCUSSION
We present the first report on the use of colorimetric methods for
primary detection of M. tuberculosis for the diagnosis of pulmo-
nary TB. These assays were simple to use and showed low contam-
ination levels with relatively short times to positive results, com-
pared with standard culture methods; however, they had
disappointing performances.
The NRA method showed acceptable sensitivity overall
(84.6%) but had low specificity (90%). The addition of PNB in the
NRAp method slightly increased the specificity to 93%. The low
specificity might be due to false-positive results caused by contam-
inants that can cause nitrate reduction, such as Pseudomonas spp.
or Staphylococcus spp. (27, 28). This might partly explain the lower
TABLE 1 Baseline characteristics of patients included in the study (n
671 unless specified otherwise)
Characteristica Result
Median age (IQR) (yr) 38 (30–48)
Gender ratio (male/female) 49/51
No. (%) of patients referred by:
OPD 392 (58.4)
ISS clinic 257 (38.3)
Other 22 (3.3)
No. (%) of HIV-positive patients (n 637) 373 (58.6)
No. (%) of patients with clinical signs at inclusion of:
History of cough (n 671) 671 (100.0)
Fever for2 wk (n 670) 258 (38.5)
Chest pain (n 663) 482 (72.7)
Hemoptysis (n 664) 78 (11.8)
Night sweats (n 663) 102 (15.4)
Reported weight loss (n 663) 488 (73.6)
No. (%) of patients (n 654) with treatment history of:
1 medication in previous 30 days 654 (100.0)
Antibiotics 425 (65.0)
Cotrimoxazole 329 (50.3)
Amoxicillin and derivatives 140 (21.4)
Anti-TB drugs1 mo before inclusion 17 (2.6)
Previous antiretroviral treatment 176 (26.9)
Antiretroviral treatment at inclusion 81 (12.4)
No. (%) of patients (n 611) with chest X-ray outcomes of:
No TB 259 (42.5)
Maybe TB 215 (35.4)
Definitely TB 135 (22.1)
a OPD, outpatient department; ISS, immune suppression syndrome.
TABLE 2 Results of colorimetric assays at day 18 according to reference
standard results (n 671)
Colorimetric
assay and result
No. with reference standard results of:
Negative MTBC NTM Contaminated
NRA
Negative 399 21 6 26
Positive 45 115 1 13
Contaminated 33 4 1 7
NRAp
Negative 399 21 6 26
MTBC 32 111 0 6
NTM 13 4 1 7
Contaminated 33 4 1 7
RETAp
Negative 450 40 6 30
MTBC 3 99 0 0
NTM 3 0 1 0
Indeterminate 2 0 0 1
Contaminated 19 1 1 15
TABLE 3 Results of colorimetric assays at day 28 according to reference
standard results (n 671)
Colorimetric
assay and result
No. with reference standard results of:
Negative MTBC NTM Contaminated
NRA
Negative 392 19 6 24
Positive 53 118 1 15
Contaminated 32 3 1 7
NRAp
Negative 392 19 6 24
MTBC 40 114 0 8
NTM 13 4 1 7
Contaminated 32 3 1 7
RETAp
Negative 448 24 7 27
MTBC 5 114 0 2
NTM 3 0 1 0
Indeterminate 1 1 0 1
Contaminated 19 1 0 16
Boum et al.
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contamination rate observed for the NRA (6.7%) than for LJ me-
dium culture (22.1%). An additional step of ZN microscopy
and/or M. tuberculosis identification rapid testing for positive
samples might improve NRA specificity.
In contrast, the RETAp had excellent specificity (99.3%) but its
sensitivity (71.2%) was relatively low at day 18, especially among
smear-negative patients (50%). Extending detection to 28 days
instead of 18 days increased the sensitivity to 82.6%, and an addi-
tional reading after 28 days should be systematically planned for
negative RETAp samples.
The performances of the colorimetric methods for primary M.
tuberculosis detection seem to be slightly lower than the perfor-
mances of MODS testing and TLA culture from a recent system-
atic review, with sensitivities of 92% (95% CI, 87 to 97%) for
MODS assays and 87% (95% CI, 79 to 94%) for TLA culture and
specificities of 96% (95% CI, 90 to 100%) for MODS assays and
98% (95% CI, 94 to 100%) for TLA culture (9). However, the
performances of RETAp after 28 days are comparable to those of
MODS assays in studies including both smear-positive and smear-
negative specimens and using liquid and solid cultures as refer-
ence standards (9, 10). Nevertheless, compared with these other
noncommercial assays, the colorimetric methods provide impor-
tant advantages in terms of ease of interpretation, because they
rely on a color change instead of observation of microcolonies
under the microscope (10, 29, 30) and thus probably are much less
prone to interuser variability. Comparisons of accuracy, interuser
reproducibility, and time to detection between these noncommer-
cial rapid cultures would be helpful.
LJ medium culture remains the most-used culture method for
diagnosing TB in developing countries, although it is less sensitive
than MGIT culture (31). In this first study on colorimetric meth-
ods for M. tuberculosis detection, RETAp M. tuberculosis recovery
results seem to be comparable to LJ medium culture results. How-
ever, the positive detection rate for LJ medium culture might be
underestimated because of the large proportion of contaminated
results for LJ medium culture, which represented 14.2% of the
positive results with MGIT culture and 0% with the RETAp.
The lower rate of contamination for the RETAp might be due to
the addition of PANTA in the tube as well as the use of four tubes
for RETAp detection, compared with two tubes for LJ medium
culture. These results should be confirmed in another study but
they are encouraging, taking into consideration the short time to
positivity of the RETAp, compared with LJ medium culture (me-
dian, 10 days versus 25 days).
TABLE 4 Performance of colorimetric methods for all, smear-negative, or HIV-positive patients with suspected TB at day 18a
Assay and patient
group
Sensitivity
(% [95% CI])
Specificity
(% [95% CI])
PPV
(% [95% CI])
NPV
(% [95% CI])
Positive LR
(95% CI)
Negative LR
(95% CI)
NRA
All 84.6 (77.4–90.2) 90.0 (86.7–92.5) 71.9 (64.2–78.7) 95.0 (92.5–96.9) 8 (6–11) 0.17 (0.12–0.25)
Smear negative 61.8 (43.6–77.8) 90.0 (86.9–92.7) 32.3 (21.2–45.1) 96.8 (94.7–98.3) 6 (4–9) 0.42 (0.28–0.65)
HIV positive 78.1 (66.9–86.9) 88.5 (84.0–92.1) 65.5 (54.6–75.4) 93.5 (89.7–96.3) 7 (5–10) 0.25 (0.16–0.38)
NRAp
All 84.1 (76.7–89.9) 92.6 (89.7–94.9) 77.6 (69.9–84.2) 95.0 (92.5–96.9) 11 (8–16) 0.17 (0.12–0.25)
Smear negative 58.1 (39.1–75.5) 92.8 (89.9–95.0) 36.7 (23.4–51.7) 96.8 (94.7–98.3) 8 (5–12) 0.45 (0.30–0.68)
HIV positive 77.5 (66.0–86.5) 91.7 (87.5–94.8) 72.4 (60.9–82.0) 93.5 (89.7–96.3) 9 (6–14) 0.25 (0.16–0.38)
RETAp
All 71.2 (62.9–78.6) 99.3 (98.1–99.9) 97.1 (91.6–99.4) 91.8 (89.0–94.1) 107 (35–334) 0.29 (0.22–0.38)
Smear negative 25.7 (12.5–43.3) 99.3 (98.1–99.9) 75.0 (42.8–94.5) 94.5 (92.1–96.4) 39 (11–136) 0.75 (0.62–0.91)
HIV positive 63.0 (50.9–74.0) 98.8 (96.6–99.8) 93.9 (83.1–98.7) 90.4 (86.3–93.5) 54 (17–168) 0.37 (0.28–0.51)
a PPV, positive predictive value; NPV, negative predictive value; LR, likelihood ratio.
TABLE 5 Performance of colorimetric methods for all, smear-negative, or HIV-positive patients at day 28
Assay and patient
group
Sensitivity
(% [95% CI])
Specificity
(% [95% CI])
PPVa
(% [95% CI])
NPV
(% [95% CI])
Positive LR
(95% CI)
Negative LR
(95% CI)
NRA
All 86.1 (79.2–91.4) 88.1 (84.7–90.9) 69.0 (61.5–75.8) 95.4 (92.9–97.2) 7 (6–9) 0.16 (0.10–0.24)
Smear negative 64.7 (46.5–80.3) 88.3 (84.8–91.1) 29.7 (19.7–41.5) 97.0 (94.9–98.5) 6 (4–8) 0.40 (0.25–0.63)
HIV positive 78.1 (66.9–86.9) 88.5 (84.0–92.1) 65.5 (54.6–75.4) 93.5 (89.7–96.3) 7 (5–10) 0.25 (0.16–0.38)
NRAp
All 85.7 (78.6–91.2) 90.7 (87.6–93.2) 74.0 (66.4–80.8) 95.4 (92.9–97.2) 9 (7–13) 0.16 (0.10–0.24)
Smear negative 61.3 (42.2–78.2) 90.9 (87.8–93.5) 32.8 (21.0–46.3) 97.0 (94.9–98.5) 7 (4–10) 0.43 (0.27–0.66)
HIV positive 80.3 (69.1–88.8) 89.3 (84.9–92.8) 67.9 (56.8–77.6)) 94.2 (90.4–96.8) 8 (5–11) 0.22 (0.14–0.35)
RETAp
All 82.6 (75.2–88.5) 98.9 (97.4–99.6) 95.8 (90.5–98.6) 94.9 (93.5–96.7) 75 (31–180) 0.18 (0.12–0.25)
Smear negative 50.0 (32.4–67.6) 98.9 (97.4–99.6) 77.3 (54.6–92.2) 96.3 (94.2–97.8) 45 (17–115) 0.51 (0.36–0.71)
HIV positive 77.8 (66.4–86.7) 98.0 (95.5–99.4) 91.8 (81.9–97.3) 94.0 (90.5–96.5) 40 (17–96) 0.23 (0.15–0.35)
a PPV, positive predictive value; NPV, negative predictive value; LR, likelihood ratio.
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The performances of RETAp at day 28 are slightly lower than
performances of the Xpert MTB/RIF test reported in numerous
studies on this new method (pooled sensitivity values of 88%
[95% CI, 83 to 92%] overall, 68% [95% CI, 59 to 75%] among
smear-negative patients, and 76% [95% CI, 63 to 85%] among
HIV-positive patients in reference 32). Culture methods in gen-
eral cannot compare with this molecular test in terms of the time
to obtain results and the simplicity of use. The main advantages of
culture methods over the Xpert assay are that they can test for
susceptibility to multiple drugs, as opposed to rifampin alone (6),
and they allow the storage of cultured strains for quality control
and further investigations. Culture methods also are more afford-
able for settings with existing culture-testing capacity; the Xpert
MTB/RIF assay costs $10, compared with the homemade colori-
metric media (less than $1 per specimen). However, in contrast to
the Xpert MTB/RIF assay, all other culture methods require P2/P3
levels of safety equipment for the culture of M. tuberculosis.
Our study was limited by the lower-than-expected number of
smear-negative and culture-positive specimens in our sample,
which resulted in wide confidence intervals for analyses in this
subgroup. This was due to overestimation of the M. tuberculosis
growth in specimens from smear-negative patients with suspected
pulmonary TB, based on a previous report of 10 to 20% in the
region (22, 24, 25). Another limitation was the high contamina-
tion rates for LJ and MGIT media. Despite the high quality of the
standard laboratory procedures, as confirmed by external moni-
tors from the supranational reference laboratory at the Institute of
Tropical Medicine (Antwerp, Belgium), contamination rates re-
mained high (22%) throughout the study. A possible explanation
is that our broad inclusion criterion, defined as cough lasting
more than 2 weeks, might have led to inclusion of patients with
diseases other than TB, caused by pathogens such as Pseudomonas
spp. or Staphylococcus spp., which are known to be resistant to our
decontamination process.
In conclusion, this first evaluation of colorimetric methods as
noncommercial alternatives to MGIT culture for rapid M. tuber-
culosis culture-based detection shows disappointing results in
terms of performance. The low specificity of the NRA, even after
the addition of PNB, precludes it from being used for primary M.
tuberculosis detection. However, the RETAp might have a place in
laboratories already using LJ medium culture, to speed up culture
results and potentially to reduce culture contamination. In addi-
tion, the ease of reading of the results is an advantage compared
with other noncommercial culture methods. Further evaluation
of the RETAp for diagnosis of TB in comparison with other non-
commercial culture methods would be necessary.
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